Fig. 2From: The correlation between HTA recommendations and reimbursement status of orphan drugs in EuropeRelationship between the share (%) of assessed orphan drugs (x-axis) and the share (%) of assessed drugs with positive and conditional HTA recommendations (y-axis). Source: Authors’ own calculations based on information from the websites of the eight HTA agencies. Note: Countries where there are special criteria for orphan drugs in the HTA process are marked in boldBack to article page